| Sep 13 |
Syra Health Announces Closing of $2.1 Million Public Offering
|
| Sep 12 |
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 12 |
Syra Health stock dips after pricing about $2.1M securities offering at $0.64
|
| Sep 12 |
Syra Health Announces Pricing of $2.1 Million Public Offering
|
| Aug 16 |
Syra Health Receives Nasdaq Notice; Files Prospectus for Securities Sale -- Shares Drop
|
| Aug 15 |
Syra Health files to offer 3.79M shares of Class A common stock
|
| Aug 12 |
SYRA: Revenue and Margins Expand in 2Q24
|
| Aug 10 |
Syra Health Second Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.18 loss in 2Q 2023)
|
| Aug 9 |
Syra Health reports Q2 results
|
| Aug 8 |
Syra Health Announces Second Quarter 2024 Financial Results, Led by Strong Revenue Growth of 101%
|
